Science Corp implants vision chip in first patient to treat Stargardt disease
Science Corporation has implanted its vision-restoring microchip in its first patient, who has Stargardt disease. The company's CEO, Max Hodak, discussed the procedure at the TechCrunch Disrupt event. This implant is part of the company's broader development of a novel brain-computer interface. The technology, called PRIMA, is designed to restore some visual function.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in